These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15193246)

  • 1. The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor.
    Obrzut SL; Halpern BS; Monchamp T; Grabski K; Watts WJ; Czernin J
    Mol Imaging Biol; 2004; 6(3):126-30. PubMed ID: 15193246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.
    Dong A; Wang Y; Dong H; Gong J; Cheng C; Zuo C; Lu J
    Clin Nucl Med; 2014 Feb; 39(2):113-21. PubMed ID: 23797227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
    Onal C; Oymak E; Findikcioglu A; Reyhan M
    Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT imaging of follicular dendritic cell sarcoma of the mediastinum.
    Subesinghe M; Smith JT; Chowdhury FU
    Clin Nucl Med; 2012 Feb; 37(2):204-5. PubMed ID: 22228355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
    Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
    BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis.
    Chatziioannou S; Papamichos O; Gamaletsou MN; Georgakopoulos A; Kostomitsopoulos NG; Tseleni-Balafouta S; Papaparaskevas J; Walsh TJ; Pneumaticos SG; Sipsas NV
    J Orthop Surg Res; 2015 Aug; 10():132. PubMed ID: 26306506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Mediastinal Leiomyosarcoma Demonstrated on FDG PET/CT Imaging.
    Wu X; Huang Y; Li Y; Wang H; Jiang L
    Clin Nucl Med; 2019 Mar; 44(3):e158-e160. PubMed ID: 30624267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Utility of 18 F-FDG PET/CT in Monitoring Corticosteroid Therapy in Inflammatory Pseudotumor.
    Sicilia Pozo MLN; García Zoghby L; López de la Osa García A; Sotillo Sánchez R; Poblete García VM
    Clin Nucl Med; 2024 Mar; 49(3):e115-e117. PubMed ID: 38271259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory pseudotumour of the infratemporal fossa visualized with
    Cabrera Villegas A; González Juez B; Llorente Pendás JL; Albornoz Almada MC; Santos Holgueras P; Sanchez Rodriguez IE
    Rev Esp Med Nucl Imagen Mol; 2017; 36(6):392-395. PubMed ID: 28495645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic pemphigus as a first sign of metastatic retroperitoneal inflammatory myofibroblastic tumor: (18)F-FDG PET/CT findings.
    Dhull VS; Passah A; Rana N; Arora S; Mallick S; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):260-2. PubMed ID: 26740314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
    Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
    Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.